SHERYL BURKE: Open Payments
NPI 1497129027 · CHIEFLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 18 payments from 9 companies in 2025. Trend: 2023 $89 · 2024 $265 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $64 |
| PFIZER INC. | 3 | $54 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Exact Sciences Corporation | 2 | $35 |
| Lilly USA, LLC | 2 | $33 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: QULIPTA, ELIQUIS, SHINGRIX, Cologuard Collection Kit, MOUNJARO, Jornay PM, PREVNAR 20, AIRSUPRA.
Industry payments across FL — which companies pay providers there.
